FDA Social Media Guidance: To be or not to be?

It has been interesting to read over the last few weeks that the FDA have delayed their Guidance on Social Media again. Some see it as irresponsible, as habits are already forming in the biopharmaceutical sector, others have described it as walking around with a blindfold on and hoping they won’t hit anything too sharp [...]

Read more »